Acworth Pharmaceuticals, Inc. Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
Acworth Pharmaceuticals (2018-2023) pioneered the discovery and development of first-in-class regulatory therapeutic candidates to kill cancer by restoring normal cellular function by creating mimetics of the vital intra-cellular regulatory protein, DKK-3b.